Table 4.
Injection drug use, %c | Shared injection equipment, %c | Condomless sex, %c | |||||||
---|---|---|---|---|---|---|---|---|---|
Studya | Nb | Ever use: yes | Ever use: don’t know, refused, missing | Recent use: yes | Recent: don’t know, refused, missing | Recent use | Recent use: don’t know, refused, missing | Recent | Recent: don’t know, refused, missing |
BRIGHT | |||||||||
BRIGHT 1 | 2405 | 22.4 | 0.04 | 4.3 | 12.3 | 1.1 | 12.3 | 49.9 | 12.7 |
BRIGHT 2 | 100 | 51.0 | 10.0 | 2.0 | 16.0 | 1 | |||
CARE+ | |||||||||
RCT | 112 | 14.3 | 1.8 | 4.5 | 6.3 | 3.6 | 5.4 | 78.6 | 3.6 |
HCV RIDOC | 250 | 17.6 | 10.0 | 4.4 | − | ||||
HCV PROB | 138 | 13.0 | 4.4 | 1.5 | − | ||||
IMPACT | 381 | − | − | − | − | ||||
LINK LA | 356 | − | − | − | 54.8 | 3.7 | |||
NEW HOPE | 123 | 86.2 | 3.3 | 64.2 | 3.3 | 17.9 | 4.9 | 25.2 | 3.3 |
STT | 3963 | 10.5 | 0.8 | 6.1 | 1.2 | 3.9 | 0.9 | 49.1 | 10.8 |
STT ILLINOIS | |||||||||
OPT OUT | 236 | − | 7.6 | − | − | ||||
CM JAIL | 376 | − | 8.0 | 0.3 | 2.7 | 0.3 | 28.5 | 2.7 | |
CM PRISON | 90 | − | 8.9 | 1.1 | 3.3 | 1.1 | 38.9 | 1.1 | |
START | 195 | − | 3.6 | − | 25.1 | 0.5 | |||
STRIDE | |||||||||
STRIDE 1 | 50 | 76.0 | 4.0 | 34.0 | 4.0 | 4.0 | 8.0 | 4.0 | 6.0 |
STRIDE 2 | 109 | 49.5 | 15.6 | 3.7 | 0.9 | 17.4 | 6.4 | ||
SUCCESS | 56 | − | 10.7 | − | 51.8 | 3.6 | |||
UHS II | |||||||||
UHS IIC | 2090 | 43.0 | 26.5 | − | 64.5 | 0.05 | |||
UHS IIL | 48 | 37.5 | 22.9 | 52.1 |
CJ criminal justice, STTR seek, test, treat and retain
aStudy acronyms as in Table 1
bThere are 33 participants who are included in more than one sub-study: 3 in BRIGHT 1 and BRIGHT 2, and 30 in UHSIIC and UHSIIL
cReference periods differed across studies; 30 days: STRIDE 1, NEWHOPE, START, SUCCESS, 90 days: BRIGHT 1 and 2, STRIDE 2, all STT Illinois studies, CARE + HCV RIDOC, CARE + RCT, STT, 180 days: LINK LA, UHS II. The following studies measured pre-incarceration risk behaviors: CARE+ RCT, CARE+ HCV RIDOC, LINK LA, NEW HOPE, STT, STT ILLINOIS OPT OUT, STT ILLINOIS CM JAIL, and STT ILLINOIS CM PRISON